Intratumoral technology
Search documents
Intensity Therapeutics(INTS) - Prospectus(update)
2023-06-09 19:20
As filed with the Securities and Exchange Commission on June 9, 2023. Registration No. 333-260565 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________ Amendment No. 14 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 _______________________________________________ Intensity Therapeutics, Inc. (Exact name of registrant as specified in its charter) _______________________________________________ | Delaware | 2836 | 46-148808 ...